Literature DB >> 2842777

Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro.

A Miyanohara1, M F Sharkey, J L Witztum, D Steinberg, T Friedmann.   

Abstract

Familial hypercholesterolemia is caused by a genetic deficiency of the low density lipoprotein (LDL) receptor. The Watanabe heritable hyperlipidemic (WHHL) rabbit, which is also defective in LDL receptor activity, provides an excellent animal model of homozygous familial hypercholesterolemia. As a step toward development of effective gene therapy for familial hypercholesterolemia, we have constructed a transmissible retroviral vector containing a full-length human cDNA for the LDL receptor. WHHL fibroblasts infected in vitro expressed the human receptor efficiently, as indicated by RNA and ligand blotting studies. Infected fibroblasts bound and degraded a monoclonal antibody specific for the human LDL receptor (IgGC7) in a manner comparable to that seen with normal human fibroblasts. Human LDL was also degraded by infected WHHL cells and promoted cholesterol esterification to the same degree as seen in normal human fibroblasts. Although technical problems remain to be solved, these studies show that, in principle, gene therapy may be possible for familial hypercholesterolemia patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842777      PMCID: PMC282008          DOI: 10.1073/pnas.85.17.6538

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.

Authors:  A D Miller; M F Law; I M Verma
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

Review 2.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

4.  Demonstration of functional low-density lipoprotein receptors by protein blotting in fibroblasts from a subject with homozygous receptor-negative familial hypercholesterolemia.

Authors:  C F Semenkovich; R E Ostlund; J Yang; M E Reaban
Journal:  J Lab Clin Med       Date:  1985-07

5.  Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit.

Authors:  T Yamamoto; R W Bishop; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

6.  A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

Authors:  L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits.

Authors:  R C Pittman; T E Carew; A D Attie; J L Witztum; Y Watanabe; D Steinberg
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

8.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

9.  Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors.

Authors:  J M Dietschy; T Kita; K E Suckling; J L Goldstein; M S Brown
Journal:  J Lipid Res       Date:  1983-04       Impact factor: 5.922

10.  Visualization of lipoprotein receptors by ligand blotting.

Authors:  T O Daniel; W J Schneider; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

View more
  7 in total

1.  Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.

Authors:  J H Wolfe; E H Schuchman; L E Stramm; E A Concaugh; M E Haskins; G D Aguirre; D F Patterson; R J Desnick; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.

Authors:  Olivia C Hibbitt; Eileen McNeil; Michele Mp Lufino; Len Seymour; Keith Channon; Richard Wade-Martins
Journal:  Mol Ther       Date:  2009-10-27       Impact factor: 11.454

3.  Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.

Authors:  S Ylä-Herttuala; J Luoma; H Viita; T Hiltunen; T Sisto; T Nikkari
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes.

Authors:  E I Closs; I H Borel Rinkes; A Bader; M L Yarmush; J M Cunningham
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer.

Authors:  C Peters; W Rommerskirch; S Modaressi; K von Figura
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

Review 6.  Retroviral transfer of HSV1-TK gene into human lung cancer cell line.

Authors:  Y Hasegawa; N Emi; K Shimokata
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

7.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.